Patenting Personalized Medicine: One Size Does Not Fit All

Personalized medicine, including biomarker-driven diagnostics, CAR-T cell therapies, and gene-level treatments, is creating new opportunities for life sciences innovation. But securing meaningful patent protection in this space is anything but one-size-fits-all. Traditional patent frameworks often fall short when applied to therapies tailored to individual genetic profiles, and evolving eligibility standards at the USPTO and internationally add another layer of complexity.

Watch the webinar recording as Sterne Kessler’s Paul Calvo, Ph.D. and Emily Tkac examine the challenges and practical strategies when protecting innovation in this rapidly evolving space.

Topics covered during the webinar include:

• Subject matter eligibility under Mayo/Alice and the lessons of Vanda Pharmaceuticals
• The USPTO’s guidance on AI-assisted diagnostics
• Divided infringement risks and how to avoid them
• Claim drafting strategies across the U.S., Europe, China, and Japan